Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Steady-state plasma level prediction for haloperidol from a single test dose.

J I Javaid1, P G Janicak, D Hedeker

  • 1Department of Psychiatry, University of Illinois, Chicago.

Psychopharmacology Bulletin
|January 1, 1991
PubMed
Summary

This study introduces a faster method for determining optimal haloperidol (HPDL) doses. By using a single test dose, clinicians can predict and individualize HPDL dosages to reach desired therapeutic plasma levels more efficiently.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Resemblance in physical activity levels: The Portuguese sibling study on growth, fitness, lifestyle, and health.

American journal of human biology : the official journal of the Human Biology Council·2017
Same author

Correlates of children's compliance with moderate-to-vigorous physical activity recommendations: a multilevel analysis.

Scandinavian journal of medicine & science in sports·2016
Same author

The thresholds of change model: an approach to analyzing stages of change data.

Annals of behavioral medicine : a publication of the Society of Behavioral Medicine·2008
Same author

Obesity prevention in low socioeconomic status urban African-american adolescents: study design and preliminary findings of the HEALTH-KIDS Study.

European journal of clinical nutrition·2005
Same author

An application of the thresholds of change model to the analysis of mental health data.

Mental health services research·2002
Same author

A random-effects mixture model for classifying treatment response in longitudinal clinical trials.

Journal of biopharmaceutical statistics·2002

Area of Science:

  • Pharmacokinetics and Pharmacodynamics
  • Psychiatric Pharmacology
  • Clinical Drug Dosing

Background:

  • Interindividual variability in haloperidol (HPDL) kinetics complicates achieving target steady-state plasma concentrations (Css).
  • Empirical dose adjustments are time-consuming and may not efficiently reach therapeutic levels.

Purpose of the Study:

  • To develop and validate a method for individualizing haloperidol doses.
  • To predict the required dose to achieve a desired steady-state plasma level (Css) based on early pharmacokinetic data.

Main Methods:

  • A single 15-mg oral haloperidol (HPDL) test dose was administered to 28 acutely psychotic patients.
  • Plasma HPDL levels were measured at 24 and 48 hours post-test dose.
  • Linear regression analysis modeled the relationship between test dose plasma levels, final Css, and required dose.

Related Experiment Videos

Main Results:

  • A strong linear relationship was observed between log Css and log dose (R2 = .78).
  • Adding the 24-hour post-test dose plasma level significantly improved this relationship (R2 = .87).
  • This indicates predictability of Css based on early HPDL levels.

Conclusions:

  • A method utilizing a single HPDL test dose and 24-hour plasma level can effectively individualize dosing.
  • This approach offers a more efficient strategy for achieving therapeutic haloperidol Css, reducing empirical dose titration time.